Evidence map›Paper›PMID 35207767›Full record

ArticleJournal of personalized medicine2022

Age-Related Changes in Lipid and Glucose Levels Associated with Drug Use and Mortality: An Observational Study.

Rene Markovič, Vladimir Grubelnik, Helena Blažun Vošner, Peter Kokol, Matej Završnik, Karmen Janša, Marjeta Zupet, Jernej Završnik, Marko Marhl

Open access · goldAbstract read
In one paragraph

Article in Journal of personalized medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. eHealth profile of patients with diabetes.Frontiers in public health · 2023
    Article
  6. The Aging Process: A Metabolomics Perspective.Molecules (Basel, Switzerland) · 2022
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Rene MarkovičFaculty of Natural Sciences and Mathematics, University of Maribor, 2000 Maribor, Slovenia.ORCID 0000-0001-9068-6373
Vladimir GrubelnikFaculty of Electrical Engineering and Computer Science, University of Maribor, 2000 Maribor, Slovenia.ORCID 0000-0002-4182-8520
Helena Blažun VošnerCommunity Healthcare Center Dr. Adolf Drolc Maribor, 2000 Maribor, Slovenia.ORCID 0000-0003-1998-7346
Peter KokolFaculty of Electrical Engineering and Computer Science, University of Maribor, 2000 Maribor, Slovenia.ORCID 0000-0003-4073-6488
Matej ZavršnikDepartment of Endocrinology and Diabetology, University Medical Center Maribor, Ljubljanska ulica 5, 2000 Maribor, Slovenia.
Karmen JanšaThe Health Insurance Institute of Slovenia, Miklošičeva cesta 24, 1507 Ljubljana, Slovenia.
Marjeta ZupetThe Health Insurance Institute of Slovenia, Miklošičeva cesta 24, 1507 Ljubljana, Slovenia.
Jernej ZavršnikFaculty of Natural Sciences and Mathematics, University of Maribor, 2000 Maribor, Slovenia.
Marko MarhlFaculty of Natural Sciences and Mathematics, University of Maribor, 2000 Maribor, Slovenia.ORCID 0000-0003-0387-1162
University of Maribor · SIAlma Mater Europaea · SIHealth Insurance Institute of Slovenia · SIUniversity Clinical Centre Maribor · SI

Funding

Slovenian Research Agency P1-0055, IO-0029
6 · The paper itself

Abstract

backgroundThe pathogenesis of type 2 diabetes mellitus is complex and still unclear in some details. The main feature of diabetes mellitus is high serum glucose, and the question arises of whether there are other statistically observable dysregulations in laboratory measurements before the state of hyperglycemia becomes severe. In the present study, we aim to examine glucose and lipid profiles in the context of age, sex, medication use, and mortality.

methodsWe conducted an observational study by analyzing laboratory data from 506,083 anonymized laboratory tests from 63,606 different patients performed by a regional laboratory in Slovenia between 2008 and 2019. Laboratory data-based results were evaluated in the context of medication use and mortality. The medication use database contains anonymized records of 1,632,441 patients from 2013 to 2018, and mortality data were obtained for the entire Slovenian population.

resultsWe show that the highest percentage of the population with elevated glucose levels occurs approximately 20 years later than the highest percentage with lipid dysregulation. Remarkably, two distinct inflection points were observed in these laboratory results. The first inflection point occurs at ages 55 to 59 years, corresponding to the greatest increase in medication use, and the second coincides with the sharp increase in mortality at ages 75 to 79 years.

conclusionsOur results suggest that medications and mortality are important factors affecting population statistics and must be considered when studying metabolic disorders such as dyslipidemia and hyperglycemia using laboratory data.

Indexed as

agingdiabeteshematological datametabolic syndrome

Identifiers

PMID35207767
PMCPMC8876997
OpenAlexW4212851649

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.